BIO-RAD LABORATORIES INC
For the period ended Dec 31, 2023. Filed Feb 16, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 16, 2024
BIO$386.48-0.5%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Financial Statements and Supplementary Data
| Index to Consolidated Financial Statements | |
|---|---|
| Page | |
| Reports of Independent Registered Public Accounting Firm | 36 |
| Consolidated Balance Sheets at December 31, 2023 and 2022 | 39 |
| Consolidated Statements of Income (Loss) for each of the three years in the period ended | |
| December 31, 2023 | 41 |
| Consolidated Statements of Comprehensive Income (Loss) for each of the three years in the | |
| period ended December 31, 2023 | 42 |
| Consolidated Statements of Cash Flows for each of the three years in the period ended | |
| December 31, 2023 | 43 |
| Consolidated Statements of Changes in Stockholders’ Equity for each of the three years | |
| in the period ended December 31, 2023 | 44 |
| Notes to Consolidated Financial Statements | 45 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.